| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.5B | $39.3B | $45.6B | $47.8B | $38.4B | $28.4B | $31.9B | $8.6B |
| Cost of Revenue | $34.3B | $37.5B | $43.2B | $45.7B | $37.5B | $27.4B | $30.5B | $8.2B |
| Gross Profit | $1.1B | $1.8B | $2.4B | $2.1B | $1.0B | $1.0B | $1.4B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.0B | $1.2B | $1.0B | $1.0B | $0.7B | $0.7B | $0.7B | $0.2B |
| Operating Income | $0.1B | $0.6B | $1.3B | $1.1B | $0.2B | $0.3B | $0.7B | $0.2B |
| Net Income | $0.6B | $1.1B | $1.9B | $1.7B | $0.6B | $0.4B | $0.8B | $0.2B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.9B | $18.7B | $19.0B | $18.8B | $17.6B | $16.0B | $16.4B | $16.4B |
| Current Assets | $8.1B | $8.7B | $9.1B | $9.4B | $8.0B | $6.3B | $6.7B | $6.7B |
| Cash & Equivalents | $0.3B | $0.8B | $1.8B | $0.8B | $0.4B | $0.1B | $0.2B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.3B | $5.4B | $5.9B | $7.0B | $6.3B | $4.9B | $5.6B | $5.9B |
| Stockholders' Equity | $11.1B | $10.8B | $10.4B | $9.5B | $9.0B | $8.8B | $8.6B | $8.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $1.3B | $3.3B | $1.9B | $0.8B | $1.1B | $1.1B | $1.1B |
| Investing Cash Flow | $-0.9B | $-1.4B | $-1.0B | $-0.5B | $-0.1B | $-0.2B | $-0.7B | $-0.1B |
| Capital Expenditures | $0.7B | $0.8B | $0.6B | $0.4B | $0.3B | $0.4B | $0.4B | $0.4B |
| Financing Cash Flow | $-0.2B | $-0.8B | $-1.4B | $-1.1B | $-0.3B | $-0.9B | $-0.7B | $-0.7B |